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Alloantisera prepared in strain 13 guinea pigs by immunization with strain 
2  lymphoid  cells markedly inhibit  the  activation  of  (2  X  13)F1  peritoneal 
exudate  lymphocytes by  the  2,4-dinitrophenyl  (DNP)  derivative  of  a  co- 
polymer of L-glutamic acid and L-lysine (GL)  1 (1). Responses to DNP-GL and 
to the closely related antigen,  DNP-poly-L-lysine (DNP-PLL), depend upon 
the presence of an immune response (Ir) gene linked to the major histocom- 
patibility  complex  (MHC)  controlling  the  strain  2  ailoantigen(s)  (2).  This 
finding, with appropriate specificity controls, has led us to propose that allo- 
antisera  inhibit  antigen  recognition  by  thymus-dependent  (T)  lymphocytes 
through interference with the activity of Ir gene products (1). 
In the first paper (3) of this series, we examined the effect of absorption of the 
13 anti-2 serum with different populations of immunocompetent cells. We were 
unable to demonstrate a clear dissociation between the ability of a cell popula- 
tion to remove the cytotoxic activity of the anti-2 serum for lymphocytes and 
the ability of that population to remove the capacity of the anti-2 serum to 
inhibit T-cell proliferation in response to DNP-GL. We concluded that the 13 
anti-2 serum contains antibodies directed against cell surface structures present 
on  both  thymus-derived  (T)  lymphocytes  and  bone  marrow-derived  (B) 
lymphocytes, because L2C leukemia cells,  a  pure population of malignant B 
lymphoid cells, were able to remove both the cytotoxic capacity and the T-cell 
inhibitory capacity from the anti-2 serum. Indeed, the relevant antigens appear 
to be present in larger amount on B cells than on T  ceils. It is possible that the 
anti-2  serum contains different populations of antibodies,  some of which  are 
reactive with strain 2 histocompatibility (H)  antigen(s)  and other which are 
t Abbreviations used in this paper: CFA, complete Freund's adjuvant; GA, a copolymer  of 
L-glutamic acid and L-alanine; GL, a copolymer  of L-glutamic  acid and L-lysine;  GT, a copoly- 
mer of L-glutamic acid and L-tyrosine; H, histocompatibility; Ir, immune response; MHC, 
major histocompafibility complex; NGPS, normal guinea pig serum; PEC, peritoneal exu- 
date ceils; PELs, peritoneal exudate lymphocytes; PHA, phytohemagglutinin; PLL, poly-L- 
lysine; PPD, purified protein derivative of tuberculin; SI, stimulation index. 
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reactive with the products of the Ir genes. According to this interpretation both 
the products of the Ir genes and the relevant alloantigen would be expressed 
on the surface of B lymphocytes. 
In order to further study whether the inhibitory antibodies within the allo- 
anfisera are directed against H  antigens or against the products of the Ir genes, 
it would be advantageous to analyze the ability of alloantisera to inhibit T-cell 
proliferation  to  an  antigen,  the  response to which  is under  the  control  of a 
specific Ir gene, in the absence of the H  antigen which usually occurs in asso- 
ciation with that Ir gene. Unfortunately, in progeny of crosses of (2  X  13)F1 
and parental animals, no recombinant chromosomes in which the DNP-GL Ir 
gene has been separated from the H  gene to which it is normally linked have 
yet  been identified.  An  alternate  approach  to this  goal is to utilize  outbred 
animals in which relationships between H  and Ir genes exist which differ from 
those obtaining in inbred populations. Table I  reviews the previously reported 
(2, 4,  7)  associations between responsiveness to PLL, responsiveness to a  co- 
polymer of L-glutamic acid and L-alanine (GA) and possession of strain 2 and 
13 H  specificities. Inbred strain 2 animals response to both PLL and GA, while 
inbred  strain  13  animals  respond  to  neither  of  these  antigens;  (2  X  13)F1 
animals  respond  to  both  PLL  and  GA.  Some  (2  X  13)F1  X  13  backcross 
progeny respond to GA and to PLL; their cells can be lysed by an anti-2 serum 
in the presence of complement. On the other hand, the GA nonresponder back- 
cross animals also fail to respond to PLL and their cells cannot be lysed by an 
anti-2 serum. Thus, in inbred strain 2 animals, the GA Ir gene is linked to the 
PLL Ir gene and to the gene(s)  controlling strain  2 H  antigen(s).  However, 
this relationship is not observed in all outbred animals. Thus, outbred Hartley 
guinea pigs can be divided into four main groups on the basis of their responses 
to GA, PLL, and the ability of anti-2 or anti-13  sera to lyse their lymphoid 
cells.  Group I  outbred animals respond to both PLL and  GA and their cells 
are lysed  by an  anti-2  serum,  but  not  by  an  anti-13  serum;  these  animals 
therefore  resemble  inbred  strain  2  animals.  Group  II  outbreds  respond  to 
TABLE I 
Rdationship between Histocompatibility Type and Responsiveness to PLL and GA 
Strain  Phenotype  PLL response  GA respones 
Inbred 2  2+/2  +  +  + 
Inbred 13  13+/13  +  --  -- 
(2 X  13)Ft  . 2+/13  +  +  + 
2+/13+  +  + 
(2 X 13)Ux X  13  [13+/13+  _  _ 
Outbred I  2+/13  -  -4-  + 
Outbred II  2-/13  +  --  -- 
Outbred III  2+/13  +  -4-  + 
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neither PLL nor GA and their cells are lysed by an anti-13, but not by an 
anti-2 serum. The members of this group thus resemble inbred strain 13  ani- 
mals. Group III animals respond to both PLL and GA and their cells are lysed 
both  by  an  anti-2  and  by  an  anti-13  serum.  These  animals thus  resemble 
(2  X  13)F1 animals. A  4th group of Hartley animals responds to GA, but not 
PLL, and their cells are lysed by an anti-13 but not by an anti-2 serum. This 
last group contains the proposed recombinant chromosome. 
In the present study, we have used this group of  GA+PLL-2-13  +  animals 
in an attempt to demonstrate whether the anti-2 serum can inhibit the func- 
tion of an Ir gene which is normally linked to strain 2 H  genes, when this gene 
occurs in an animal lacking strain 2  H  genes.  We also report  the results of 
attempts to prepare  an alloantiserum capable of inhibiting the  GA response 
and devoid of anti-2 activity by immunizing strain 13 animals with cells from 
these outbred animals. 
Materials and Methods 
Animals.--Inbred strain 2 and strain 13 guinea pigs were obtained from the Division of 
Research Services, National Institutes of Health, Bethesda, Md. (2 X 13)Fx  animals were ob- 
obtained by mating strain 2 with strain 13 animals in our own colony. Outbred Hartley guinea 
pigs were obtained from Camm Research Institute Inc., Wayne, N. J. 
Antigons.--Poly-L-lysine.IiBr  (PLL, mol wt  110,000), a  copolymer of z-glutamic acid 
(60%), and L-lysine (40%) (GL, mol wt 115,000) and a copolymer of z-glutamic acid (60%), 
and L-aianine (40%) (GA, tool wt 43,000), were obtained from the Pilot Chemical Division 
of the New England Nuclear Corp., Boston, Mass. DNP21-PLL and DNPs-GL were prepared 
as previously described (8). The subscript refers to the number of DNP groups/molecule. 
Purified protein derivative  of tuberculin  (PPD)  was purchased  from Connaught Medical 
Research Laboratories,  Willowdale, Ontario,  Canada.  Phytohemagglutinin  (PHA) was ob- 
tained from Welcome Research Laboratories, Beckenham, England. 
Immunization  of Guinea Pigs.--Solutions  of each antigen were emulsified with an equal 
volume of complete Freund's adjuvant containing 0.5 mg of Mycobacterium butyricum/ml 
(CFA, Difco Laboratories,  Detroit,  Mich.). Animals were immunized simultaneously with 
either  100/~g of DNP-GL or 100/~g DNP-PLL  and 500 ~g of GA; each antigen was ad- 
ministered in one front footpad and one rear footpad. 
Skin  Tests.--3  wk after immunization the animals were injected intradermally  with 50 
/~g of DNP-GL or GA, or 10/~g DNP-PLL in 0.1 ml of normal saline. Animals immunized with 
adjuvant alone were similarly skin tested to evaluate the degree of nonspecifie  irritation pro- 
duced by these polymers. The injection sites were examined after 24 h; erythema and indura- 
tion greater than 8 mm in diameter was considered a positive skin test. 
Preparation of Alloantisera.--A  strain 13 antistrain 2 serum was prepared as previously 
described  (1). Strain 13  anti-GA+PLL+2+13  + Hartley and strain 13  anti-GA+PLL-2-13 + 
Har  tley sera were prepared by immunizing strain 13 animals with a CFA emulsion of 100 X l0  s 
lymph node and spleen cells from the appropriate Hartley guinea pig. 2 and 4 wk after primary 
immunization, the strain 13 animals were boosted with 100 X l0  s lymph node and spleen cells 
from a phenotypically similar animal. 6-8 wk after  the initial immunization, the strain 13 
animals were exsanguinated and the sera heat-inactivated at 56°C for 40 rain and sterilized by 
MiUipore filtration. Absorption studies of the 13 anti-2 serum were performed as described in 
the  accompanying report  (3). 
Cytotoxicity Testing.--The alloantisera were tested against 51Cr-labeled lymph node cells 
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Cell Collection and Technique of Brief Antigen Exposure.--The techniques for the collection 
of the peritoneal exudate cells (PEC)  and the methods for the purification of the peritoneal 
exudate lymphocytes (PELs) have been described previously (10). When inbred or (2 X  13)F1 
animals were used, the cells from two animals were pooled; when cells from outbred animals 
were used, the cells from each animal were processed individually. 
The technique  of brief antigen exposure of the PEC population is described in the accom- 
panying report (3). The final concentrations  in the incubation medium of the antigens used in 
this study were as follows: DNP-GL 100 #g/ml; DNP-PLL,  1 #g/ml; GA, 5 mg/ml; PPD, 
100  /zg/ml and PHA,  10/ag/ml. 
In Vitro Assay of Antigen-Induced DNA Synthesis.--The methods used in the first paper of 
this series (3) are identical to the ones used here. When studies were performed on individual 
outbred animals, the macrophages from that animal were combined only with the lymphocytes 
from that same animal. The results are expressed as either total cpm per culture, as the dif- 
ference between control and antigen stimulated cultures (A cpm), or as the stimulation index 
(SI), the ratio of cpm incorporated in the presence  of antigen to cpm incorporated in the 
absence  of antigen. 
RESULTS 
Inhibition  of the Proliferative Response of Cells from  (2  X  13)F1 Animals to 
GA.--Before the effect of the 13  anti-2 serum on the GA response in the out- 
bred population could be analyzed, it was  necessary to demonstrate thai the 
in vitro proliferative response to GA of cells from  (2  X  13)F1 animals can be 
specifically inhibited by the anti-2 serum.  F1 animals were simultaneously im- 
munized with DNP-GL  and GA and exudate lymphocytes from those animals 
cultured with  macrophages  which  had  been  pulsed with  either  DNP-GL  or 
GA. It should be noted that high concentrations (5 mg/ml) of GA during the 
macrophage pulse step were required in order to obtain significant lymphocyte 
activation. Table II shows  the results of two  typical experiments using  cells 
from  F1 animals. In  these experiments  the in vitro proliferative responses  to 
both I)NP-GL and  GA were completely inhibited by the anti-2 serum. In ex- 
periment 2, moderate suppression of the PPD  and PHA responses was also ob- 
served indicating a  decreased capacity of this lot of antiserum to support cell 
TABLE II 
Inhibition of Proliferation by Lymphocytes from F1 (2 X  13) Animals 
Immune to DNP-GL and GA 
Serunl 
Stimulant  Exp. 1  Exp. 2 
NGPS  13 Anti-2  NGPS  13 Anti-2 
0  236*  180  2,072  1,723 
DNP-GL  11,715  198  11,115  942 
GA  2,344  299  10,175  1,903 
PPD  9,478  9,164  44,506  59,484 
PHA  25,878  29,685  33,539  66,773 
* Results are expressed as cpm per tube; each value is the mean of three determinations. ETHAN  M.  SHEVACH~ IRA  GREEN, AND WILLIAM E.  PAUL  683 
growth in culture. This study demonstrates that specific inhibition of FI T-cell 
proliferation by the anti-2 serum is not confined to antigens controlled by the 
PLL gene, but  can also be extended to the in vitro proliferative response to 
another antigen the response to which is controlled by a  2-1inked  Ir gene. 
Analysis  of PLL  and GA  Responses  in  Outbred  Animals.--Approximately 
150 Hartley guinea pigs were immunized with both DNP-PLL and GA, skin 
tested with these antigens to determine their responder status, and typed with 
both anti-2 and anti-13 sera in a aCr release assay. This particular population 
could be divided into  three  groups of animals.  One-third  of the  guinea pigs 
were  GA+PLL+2+13+;  one-third  were  GA+PLL-2-13  +,  and  one-third  were 
GA-PLL-2-13  +. In this population 2+13  -  animals were not identified although 
animals of this phenotype are seen in other outbred populations (Table I). We 
did not identify any GA-PLL  +  animals although  a  small number of animals 
of this type have been identified previously (6). 
Inhibition  of  the  Response  to  GA  of  T  Lymphocytes from  GA+PLL  +  and 
GA+PLL  -  Hartley Animals.--The PELs of GA responder Hartley guinea pigs 
of  both  types (GA+PLL+2  +,  GA+PLL-2  -)  were  cultured  in  the presence of 
antigen pulsed macrophages either in normal guinea pig serum (NGPS)  or in 
anti-2  serum. Table III illustrates  the  results  with  cells  from  GA+PLL+2  + 
animals. Table IIIA  shows the detailed results in four experiments each em- 
ploying cells from a  different individual  animal of this  type. In experiments 
1-3, marked and specific suppression of the response to both DNP-PLL and 
GA was observed; in experiment 4 the absolute number of cpm incorporated 
in response to GA was decreased in the presence of the anti-2 serum; however, 
when the results are expressed as the stimulation index, the SI is higher in the 
presence of the anti-2 serum then in the presence of normal serum. Table III B 
summarizes  the  results  in  these  four  and  nine  other  individual  experiments 
using cells from GA+PLL+2  + Hartley animals. The results are expressed as the 
SI in NGPS compared to the SI in anti-2 serum. In 9 out of 13 cases, marked 
TABLE III A 
Inhibition of Proliferation by Lymphocytes  from Ga  + PLL+2  + Hartley Guinea Pigs 
Senlln 
Stimulant  Animal 1  Animal 2  Animal 3  Animal 4 
0 
DNP-PLL 
GA 
PPD 
PHA 
NGPS  13 Anti-2 
2,989*  2,250 
37,218  6,284 
24,258  4,098 
29,261  20,118 
49,555  57,534 
NGPS 
733 
13,824 
3,046 
8,032 
9,499 
13 Anti-2 
542 
592 
545 
5,300 
7,494 
NGPS 
2,482 
67,436 
11,693 
50,094 
53,369 
13 Anti 2 
1,369 
2,601 
4,104 
34,884 
36,667 
NGPS 
4,097 
21,213 
16,537 
58,115 
47,069 
13 Anti-2 
805 
1,549 
10,380 
27,103 
34,570 
* Results are expressed as cpm per tube; each value is the mean of three determinations. 684  IMMUNE RESPONSE GENE PRODUCT FUNCTION 
TABLE III B 
Suppression  of Proliferative Response to GA by Cells from  GA+PLL+2  + ttartley Animals 
Serum 
Animal  Supplession* 
NGPS  13 Anti-2 
% 
1  8.1,  1.8  89 
2  4.1  1.0  100 
3  4.7  2.9  49 
4  4.0  12.8  -- 
5  15.4  1.5  97 
6  6.9  1.1  98 
7  12.2  5.9  56 
8  6.6  12.2  -- 
9  2.0  1.0  100 
10  3.2  4.2  -- 
11  5,3  2.6  63 
12  13.9  15.5  -- 
13  2.5  2.1  27 
* %  Suppression  =  _El --  (SI(_~  i--n-N--GP--~-l)in  anti-2 serum-1)']l  X  100. 
t sI. 
suppression of the in vitro proliferative response to  GA was  observed in  the 
presence of the  anti-2 serum.  In four cases,  the  GA response was  either un- 
changed or enhanced in the presence of the anti-2 serum. In each of these cases, 
the response to DNP-PLL  was completely inhibited by the alloantiserum. 
Table IV illustrates the effect of the anti-2 serum on the in vitro proliferative 
response to GA of cells from GA+PLL-2  -  animals. Table IV A gives the detailed 
results observed in three typical experiments. No evidence of proliferation is 
seen in response to DNP-PLL  in vitro; this confirms the unresponsiveness  of 
these animals to DNP-PLL  as demonstrated by skin tests. In experiments  1 
and 2 no suppression of the GA response was observed while in experiments 3 
moderate suppression (60 %) of the GA response was seen. Table IV B  summa- 
rizes the effect of the anti-2 serum on the GA response of cells from these three 
and six other GA+PLL-2  -  animals. In seven out of nine cases no evidence of 
suppression of the response to GA by the anti-2 serum was seen. In two cases, 
the anti-2 serum produced moderate suppression of the GA response. We con- 
clude  from  this  study  that  the  anti-2  serum  is  much  more  capable of  sup- 
pressing the GA response of cells from GA+PLL+2  + Hartley animals than cells 
from GA  + PLL-2-  Hartley animals. The observation that the response to GA 
of  cells from  some GA+2  +  animals  was  not  inhibited  is  probably  explained 
by the likelihood that  such  animals  are heterozygous  GA+2  +,  GA+2  -.  Thus, 
the ability of the anti-2 serum to inhibit the GA response appears to depend, 
in the main, on the presence of strain 2 H  antigen on the responder cells. ETHAN  M.  SHEVACH~  IRA  GREEN,  AND  WILLIAM  E.  PAUL  685 
TABLE IV A 
Inhibition  of Proliferation by Cdls from  GA+PLL-2  -  Hartley  Guinea Pigs 
Seruln 
Stimulant  Animal 1  Animal 2  Animal 2 
NGPS  13 Anti-2  NGPS  13 Anti-2  NGPS  13 Anti-2 
O  1,910"  2,038  845  810  1,145  1,300 
DNP-PLL  1,676  1,757  1,256  1,040  1,462  1,637 
GA  14,703  14,766  40,489  51,740  22,057  9,947 
PPD  19,335  17,599  135,679  144,295  31,138  29,803 
PHA  16,249  13,077  96,314  147,452  -- 
* Results are expressed as cpm per tube; each value is the mean of three determinations. 
TABLE IV B 
Suppression of Proliferative Response to GA by Cells  from GA+PLL-g  -  Animals 
Animal  NGPS  13 Anti-2  Suppression* 
% 
1  7.75  7.2  -- 
2  47.9  63.9  -- 
3  19.3  7.7  63 
4  6.6  10.9  -- 
5  3.1  4.8  -- 
6  3.1  3.1  -- 
7  11.4  18.9  -- 
8  31.6  19.5  40 
9  7.8  8.2  -- 
* For calculation see Table III B. 
5 si. 
Effect of 13 Anti-GA+PLL+2  + and 13 Anti-GA+PLL-2  -  Sera on the GA  Re- 
sponse of Cells from F1  (2  X  13) Animals.--The  results of the previous study 
suggested that  suppression  of  the  proliferative response  to  GA  is  primarily 
mediated by  antibodies directed  against  strain  2  H  antigen  rather  than  by 
antibodies specific for the GAIr  gene product. Another approach to the study 
of the same problem is to prepare an alloantiserum which might be anticipated 
to be specific for the GA Ir gene product and to be free of antibodies to strain 
2 H  antigens. To accomplish this, strain 13  animals were immunized with the 
lymph node and spleen cells of GA+PLL-2-13  + Hartley animals. As a control, 
another group of strain 13  animals were immunized with the lymph node and 
spleen cells of GA+PLL+2+13  + Hartley animals. In the former case, the result- 
ant antisera would lack anti-strain 2 antibodies whereas such antibodies should 
be present in sera obtained from the latter immunization. The cytotoxic activi- 
ties of these two sera are shown in Table V  and compared with the standard 
anti-2  and  anti-13  sera.  The  13  anti-GA+PLL+2  +  serum  contains  significant 686  iMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
TABLE V 
CytotoMcAcgNty ~AUoant~era 
Antiserum 
Target  Iymphocytes 
Inbred 2  Inbred 13  GA+PLL+2+13 + outbred  GA+PLL-2-13  + outbred 
13 anti-2  44*  0  17  0 
2 anti-13  0  31  23  31 
13 anti-  58  0  79  65 
GA+PLL+2+13+ 
13 anti-  0  0  75  73 
GA+PLL-2-13  + 
* % SlCr release from labeled lymph node cells by a 1/5 dilution of antiserum. 
cytotoxic  activity  for  strain  2  lymph  node  cells.  The  13  anfi-GA+PLL-2  - 
serum  is  devoid of anti-2  activity.  Both of these  sera  exhibit  high  levels  of 
cytotoxic activity for cells from animals of the immunizing type and also dem- 
onstrate almost equal cytotoxic activity for cells from outbred animals of the 
opposite phenotype. Thus,  the  13  anti-GA+PLL+2  + sera is  able to lyse both 
GA+PLL+2  + lymph node cells  and GA+PLL-2  -  lymph node cells. 
The ability of these sera to inhibit the proliferation of T  cells  derived from 
(2  X  13)F1 animals which have been  doubly immunized With DNP-GL and 
GA is examined in Fig. 1. The response of the F1 T  cells  to DNP-GL and GA 
was completely inhibited by the 13 anti-2 serum and by the 13 anti-GA+PLL+2  + 
serum;  these sera also produced moderate suppression  of the PPD  response. 
In contrast,  the  13-anti  GA+PLL-2  -  serum was without inhibitory effect for 
the DNP-GL,  GA or PPD responses.  Here  again,  the inhibitory capacity of 
the alloantiserum appears to be related  to its anti-strain  2 activity. There is 
no evidence to suggest that the 13 anti-GA+PLL-2  -  serum contains antibodies 
capable of inhibiting the GA response. 
Effect of 13 Anti-GA+PLL+2  + and 13 Anti-GA+PLL-2  -- Sera on the GA  Re- 
sponse  of Cells from  Outbred  Animals.--Since  both  the  13  anti-GA+PLL+2  + 
and  the  13  anti-GA+PLL-2  -  sera  exhibited  significant cytotoxic activity to- 
ward cells from animals of the immunizing type, it was of interest to examine 
the effect of these sera on the proliferative response of outbred cells  to either 
GA or DNP-PLL. As expected (Fig. 2 A) the 13 anti-GA+PLL+2  + serum pro- 
duced  suppression  of  both  the  GA  and  DNP-PLL responses  of  cells  from 
GA+PLL+2  +  animals.  However,  neither  the  13  anti-GA+PLL+2  +  nor the  13 
anti-GA+PLL-2  -  sera had any effect on the in vitro proliferative responses of 
cells  from GA+PLL-2  -  animals  (Fig.  2 B). This is particularly interesting in 
view of the fact that both of these sera demonstrate high levels of complement 
dependent  cytotoxic  activity  for  GA+PLL-2  -  ceils  (Table  V).  This  result 
suggests that the ability of an  alloantiserum  to inhibit  T-cell proliferation is 
critically dependent on the precise nature of the antigen to which the sera are 
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Effect  of Absorption  of the Anit-2  Serum with GA+PLL+2  +  or GA+PLL-2  -- 
Cells.--One possible explanation for some of the results observed in the above 
studies  is  that  the  anti-2  serum is  composed of antibodies  directed  to strain 
2 H  antigen and of antibodies specific for the products of the GA Ir gene and 
that both populations of antibodies are necessary for the inhibition of the pro- 
liferative response  to GA. According to this interpretation,  the failure  of  the 
anti-2 serum to inhibit the  GA response of cells from GA+PLL-2  -  animals is 
not due to an absence of anti-GA Ir gene product antibodies but rather to lack 
30 
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FIG. 1.  (2 X  13)F1 lymphocytes were cultured with DNP-GL, GA, PPD, or PHA pulsed 
macrophages in the presence of normal guinea pig serum, 13 anti-2 serum, 13 anti-GA+PLL +- 
2+13  + serum, or 13 anti-GA+PLL-2 - 13  + serum. Results are expressed as Acpm/culture.  Each 
bar represents the arithmetic  mean of three experiments 4-1 SEM. 
of anti-strain  2  antibodies,  the concerted action of which is required for inhi- 
bition. In order to rule out this possibility, aliquots of the 13 anti-2 serum were 
absorbed with either  GA+PLL+2  + lymphocytes or with  GA+PLL-2  -  lympho- 
cytes. The inhibitory activity of the absorbed antisera was tested on (2 X  13)F1 
lymphocytes  from  an  animal  immune  to  both  DNP-GL  and  GA  (Fig.  3). 
Absorption  of the  anti-2  serum  with  GA+PLL-2  -  cells  did not  diminish  the 
inhibitory capacity of the anti-2 serum for either the GA or DNP-GL responses, 
while absorption of the anti-2 serum with GA+PLL+2  + cells markedly decreased 
the inhibitory activity of the antisera for both the DNP-GL and GA responses 
(Fig. 3 A  and 3 B). This study lends further support to the concept that the 
inhibitory activity of the anti-2 serum is directed toward strain 2 H  specificities 
and not toward the product of the GA Ir gene. 688  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
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DISCUSSION 
In this report we have examined whether alloantisera raised against lymphoid 
cells in which a given H  gene is linked to a given Ir gene can block the function 
of the product of that Ir gene when the latter occurs without the product of the 
H  gene to which it is normally linked. Ideally, this experiment should be per- 
formed using cells from an animal whose H  region derives from a recombina- 
tion event during an observed breeding and in which adequate documentation 
of parental genotypes exists. We have not yet identified a recombination event 
separating the strain 2 H  gene(s) and the DNP-GL Ir gene or one separating 
the strain  13 H  gene(s)  and the Ir gene controlling responsiveness to the co- 
polymer of L-glutamic acid and L-tyrosine (GT). This is not surprising in view 
of the low recombination rates in mouse and human MHC and the relatively 
small  number  of backcross progeny we  have studied.  We  therefore  chose  a 
situation  in  which  an Ir gene  (the  GA gene),  which  is linked  to strain  2  H 
genes in inbred animals, is frequently present in the outbred Hartley guinea 
pig population in the absence of detectable strain 2 H  specificities. 
Initially,  we  demonstrated  that  the  anti-2  serum  was  able  to  specifically 
inhibit  the  proliferative response  to  GA of T  lymphocytes from immunized 
(2  X  13)F1  animals. Thus,  the ability of 13  anti-2  alloantisera to inhibit  the 
activation of T  lymphocytes by antigens the response to which is linked to the 
presence of strain 2 H  types is not confined to antigens the response to which 
is controlled by the PLL gene (e.g. DNP-PLL and DNP-GL). We then exam- 
ined the ability of the anti-2 serum to inhibit the GA response of cells derived 
from outbred animals that manifested both delayed hypersensitivity and anti- 
body production when immunized with GA, but lacked both the PLL Ir gene 
and the gene(s) controlling strain 2 H  specificities. As a control, we also tested 
the effect of the anti-2 serum on the cells from outbred animals that were GA  +, 
but which were also PLL  + and 2  +. It was assumed that the GA Ir gene in most 
of these latter animals is linked to both the PLL Ir gene and the gene control- 
ling strain 2 H  specificities. It should also be noted that  the  PLL Ir gene is 
very closely linked to the gene(s) controlling strain 2 H  antigens in the outbred 
population because 2-PLL  + and 2+PLL  -  animals have not yet been identified 
in  our colonies  (4). 3 Consequently,  we also examined the effect of the anti-2 
serum on the DNP-PLL response on cells from the GA+PLL+2  + animals. The 
results of these experiments demonstrated that,  in the majority of cases,  the 
anti-2  serum was capable of inhibiting  the  in  vitro proliferative response  to 
GA of T  cells derived from animals that were GA+PLL+2  +, but the serum had 
little,  if any, effect on the GA response of T  cells from GA+PLL-2  -  animals. 
A similar finding has been presented by Bluestein using cells from GA+2  + and 
GA+2  -  random bred guinea pigs (11). It thus appears that the inhibition of the 
GA response by the anti-2 serum is primarily mediated via antibodies directed 
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the GA Ir gene. In four instances (out of 13 experiments) involving cells from 
experimental animals of the GA+PLL+2  + outbred group, the anti-2 serum failed 
to suppress the GA response, but completely inhibited the response of the cells 
to DNP-PLL.  One possible explanation  for this  result  is  that  these  animals 
possessed two different chromosomes bearing the GA Ir gene. On one chromo- 
some, the GA Ir gene would be linked to both the PLL Ir gene and strain 2 H 
antigen,  while  on  the  other  chromosome,  the  GA  Ir  gene  would  be  linked 
either to strain 13 H  genes or to unknown H  genes. Recent linkage tests  2 have 
indicated  the  existence of a  GA+GT+13+2  -  chromosome in outbred  animals. 
It is  likely that  the  inhibition  by anti-2  serum of the  GA response of  cells 
derived from a GA+2  +, GA+2  -  animal would not be complete due to the contri- 
bution of the products of the GA+2  -  chromosome. The response to DNP-PLL, 
depending exclusively on products of the GA+PLL+2  + chromosome, would be 
anticipated to be completely inhibited, as it was. 
Another approach to resolving the problem of whether the inhibitory activity 
of the anti-2 serum is due to antibodies which  are directly reactive with the 
products of the Ir gene is to produce antisera which, for genetic reasons, could 
contain antibodies to the products of an Ir gene and yet be devoid of antibodies 
reactive with the H  antigen to which that Ir gene is normally linked. Lympho- 
cytes from the Hartley animals that are GA+PLL-2  -  are always lysed by an 
anti-13  serum  and  therefore  bear  at  least  some  of  the  strain  13  H  antigen 
specificities. It therefore seemed reasonable to immunize strain 13 animals with 
cells from these GA+PLL-2-13  + Hartley animals. The goal of this immuniza- 
tion procedure was the preparation of an antiserum which would suppress the 
GA response of a  strain  2 or a  (2  X  13)F1  animal and be free of antibodies 
reactive with strain 2 (or strain 13) H  antigens. Here again, as a control, strain 
13  animals were immunized with cells from GA+PLL+2+13  -  animals. In this 
case,  the putative antiserum  to  the  GAIr  gene product would  also contain 
antibodies reactive with strain 2 H  antigens. The resultant antisera were tested 
with the lymphocytes from (2  X  13)F1 animals immune to both DNP-GL and 
GA. The  alloantiserum which  contained  antibodies  reactive with strain  2 H 
antigens  (the  13  anti-GA+PLL+2+13  +  serum)  was  capable of specifically in- 
hibiting the response of F1 lymphocytes to GA and to DNP-GL. On the other 
hand, the alloantiserum devoid of anti-2 activity (the 13 anti-GA+PLL-2-13  + 
serum) was also devoid of inhibitory activity for either the GA or the DNP-GL 
responses. This further supports the hypothesis that the alloantibodies reactive 
with strain 2 H  antigens are responsible for the inhibition of the in vitro pro- 
liferative response to GA which is caused by anti-2 sera. However, it should be 
noted that no data have been presented to demonstrate that the GA Ir gene 
which is linked to the PLL gene and to strain 2 H  specificities is the same GA 
gene found in  the  GA+PLL-2-13  +  animals.  Indeed,  Bluestein  has presented 
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evidence which raises the possibility that the GA genes in these animals may 
be different (11). Despite this reservation, it appears likely to us that the in- 
hibitory activity of the alloantisera is due to antibodies specific for products 
of the strain 2 and strain 13 (2/13) H  antigen genes rather than to antibodies 
specific for the products of the Ir genes themselves. The mechanism of allo- 
antiserum  induced suppression  of Ir  gene function would  then  be by steric 
interference with the Ir gene product on the cell surface rather than by direct 
binding to it. This conclusion implies that the products of both the H  genes 
and the Ir genes are physically related on the cell surface. The implications of 
such a relationship will be discussed below. 
If anti-H antibodies  are capable of indirectly inhibiting Ir gene function, 
why did  the  13  anti-GA+PLL-2-13  +  serum  fail  to  inhibit  the proliferative 
response  to  either  GA  or  PPD  of  cells  from  Hartley  animals  of  the 
GA+PLL-2-13  + phenotype even though this serum exhibited significant com- 
plement dependent cytotoxic activity as measured by 51Cr release from these 
same cells? Although the 13 anti-GA+PLL-2-13  + serum does not contain anti- 
bodies reactive with 2 or 13 H  specificities, it should contain antibodies to H 
antigens of unknown types which are present in the outbred population. One 
possible  explanation for the failure of the 13  anti-GA+PLL-2-13  +  serum  to 
suppress the GA response of cells from GA+PLL-2-13  + animals is that the GA 
Ir gene in these animals is linked to the gene controlling strain 13 H  specifici- 
ties. Anti-13 activity is lacking in this serum as it is produced in strain 13 ani- 
mals. Indeed, as noted above, we have recently demonstrated  2 that the GAIr 
gene in GA+PLL-2-13  + animals is linked to the GT gene and very likely to the 
strain 13 H  antigen gene. One might then predict that the GA response of the 
GA+PLL-2-13  +  animals  should be inhibited by anti-13  sera.  However, pre- 
liminary studies have shown that  the anti-13 serum has no effect on the re- 
sponse of lymphocytes from GA+PLL-2-13  + animals. 
Another possible explanation for the failure of some potent cytotoxic allo- 
antisera to inhibit  the in vitro proliferative response  to  antigen is  that  the 
MHC in the guinea pig is bipartite in structure and thus similar to the MHC 
of both mice and man. If this explanation is valid, one might postulate that the 
Ir region would be very closely linked to the 2/13 locus and the products of 
these loci linked on the cell surface. Alloantibodies directed at determinants 
of a putative second, less closely linked, MHC locus might be devoid of inhibi- 
tory activity for T-lymphocyte functions.  Furthermore,  Sato  and  de  Weck 
have identified a major H  antigen (B) which is shared by strain 2 and strain 13 
animals (12). Studies to define the relationship between the 2/13 locus and the 
ABCD locus of Sato and de Weck are now in progress. Alternatively, as out- 
lined in the preceeding paper  (3),  the antigens recognized by the anti-2  and 
anti-13 sera may be the product of MHC genes which are not formally equiva- 
lent to the genes controlling the major serologic specificities in the mouse (the 
D  and K  genes)  but rather  to genes mapping within  the Ir region of mice 692  IMMUNE  RESPONSE  GENE  PRODUCT  FUNCTION 
(13,  14).  According  to  this  thesis,  the  cytolytic  antibodies  in  the  anti- 
GA+PLL-2-13  +  sera would be  directed not  at products of these critical Ir- 
related H  genes but rather at products of other genes in the MHC. Antisera 
directed at these other MHC antigens would have limited inhibitory activity 
because of the less close linkage of their genes to Ir genes. A final possibility is 
that  the  genes  controlling  the  antigens  against  which  these  13  anti- 
GA+PLL-2-13  + sera are directed are not linked to the MHC and thus their 
failure to inhibit might be due to a complete lack of linkage. Studies to evaluate 
these possibilities are now in progress. 
The model we have proposed for the mechanism whereby alloantisera medi- 
ate their suppressive effects on Ir gene product function, namely indirect block- 
ade of the Ir gene products by antibodies directly reactive with H  antigens, 
requires phenotypic linkage of the products of independent but closely linked 
genes.  Such linkage of membrane markers has interesting implications in the 
context of a fluid mosaic model of the lymphocyte surface. In this model, indi- 
vidual protein molecules are capable of free diffusion in the plane of the mem- 
brane  (15). Indeed, recent studies of ligand-induced redistribution of surface 
markers such as immunoglobulin (16), H  antigens (17)  and receptors for con- 
canavalin A  (18)  are consistent with this thesis. In such a fluid-mosaic model, 
the  maintenance  of  a  stable  relationship  between  two  determinants  would 
suggest a physical link between these moieties in order to avoid their separa- 
tion in the course of diffusion. As a specific blockade of the DNP-GL response 
of F1 cells by anti-2 sera and of the GT response by anti-13 sera implies such 
a stable relation, we suggest that on the surface of an individual immunocom- 
petent T  cell, the Ir gene product exists bound covalently or noncovalently, 
to the strain 2 (or 13) H  antigen. An interesting analogy to the genotype and 
phenotype of immunoglobulin H  chains may then be drawn. Thus, the  genes 
specifying variable (V~)  and constant  (CH) regions of immunoglobulin heavy 
chains are independent but linked in the genome. These independent,  linked 
genes produce a single polypeptide chain. One might postulate that the  genes 
for the  2/13  antigens  are  analogous  to  Ca  genes  and that  the  Ir  genes  are 
analogs of the VB genes. Thus, all T  lymphocytes would be anticipated to bear 
a  2/13-Ir complex. The 2/13  antigen would be the same on all T  cells  while 
an individual Ir gene product would have a  clonal distribution. Moreover,  a 
possible function of this 2/13 antigen "constant region" would be to mediate 
macrophage T-cell and T-cell-B-cell interaction.  Ir  gene products or closely 
related MHC-encoded structures have recently been shown to be of importance 
for both these interactions (19,  20). 
In  this  model,  it  would  be logical  to postulate  that  the  2/13-Ir  complex 
might be "immunoglobulin-like" in that it had the main structural features of 
an immunoglobulin and that it derived from the primordial genes from which 
classical immunoglobulin genes also evolved. In view of the independent evo- 
lution of these genes, it would be very unlikely that the 2/13-Ir complex would 
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one  can  envisage  an  antigen  recognition  molecule  consisting  of  an  2/13-Ir 
complex which  had  no  structural  or genetic  relationship  to  immunoglobulin 
and constituted an entirely different class of substances. The resolution of this 
problem and further progress in the understanding of T-lymphocyte antigen- 
recognition mechanisms will  depend  on further  functional  studies  of defined 
alloantisera and chemical analysis of the MHC gene products. 
SUMMARY 
It has been previously demonstrated that alloantisera  can specifically  block 
the activation of T  lymphocytes by antigens, the response to which is linked 
to the presence of histocompatibility (H) types against which the alloantisera 
are directed. Thus, strain 13 anti-2 serum can inhibit the activation of (2 X  13)Fz 
T  lymphocytes by a  DNP  derivative of a  copolymer of L-glutamic acid and 
L-lysine (DNP-GL), an antigen the response to which is controlled by a 2-1inked 
lr gene.  It was proposed that  alloantisera can inhibit  T-lymphocyte antigen 
recognition through interference with the activity of immune response (It) gene 
products.  In order to further study whether the inhibitory antibodies within 
the alloantisera are directed against H  antigens or against the products of the 
Ir genes, we have examined whether the anti-2 serum can inhibit the function 
of an Ir gene (the L-glutamic acid and L-alanine [GA] gene), which is normally 
linked to strain 2 H  genes when this gene occurs in an outbred animal lacking 
strain 2 H  genes. In the majority of cases, the anti-2 serum was capable of in- 
hibiting the in vitro proliferative response to GA of T cells derived from animals 
that were GA+2  +, but the serum had little if any effect on the GA response of T 
cells from GA+2  -  animals.  Furthermore,  an antiserum prepared in  strain  13 
animals against the lymphoid cells of a  GA+2  -  outbred animal was devoid of 
inhibitory activity on the GA response of cells from a  (2  X  13)F,,  while an 
antiserum prepared in strain 13 animals against the lymphoid cells of a GA+2  + 
outbred animal was capable of specifically inhibiting the response to  GA.  It 
thus  appears that  the inhibition  of the  GA response  by the  anti-2  serum is 
primarily mediated via antibodies directed toward strain 2 H  antigens rather 
than antibodies specific for the product of the GA Ir gene. The mechanism of 
alloantiserum induced suppression of Ir gene function would then be by steric 
interference with the Ir gene product on the cell surface, rather than by direct 
binding to it. This conclusion implies that the products of both the H  genes 
and the Ir genes are physically related on the cell surface. The implications of 
such a relationship in terms of the fluid-mosaic model of the lymphocyte sur- 
face are discussed. 
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